BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 16086820)

  • 21. Ghrelin expression in hyperplastic and neoplastic proliferations of the enterochromaffin-like (ECL) cells.
    Srivastava A; Kamath A; Barry SA; Dayal Y
    Endocr Pathol; 2004; 15(1):47-54. PubMed ID: 15067176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of neuroendocrine markers in non-small cell lung cancer.
    Sørhaug S; Steinshamn S; Haaverstad R; Nordrum IS; Martinsen TC; Waldum HL
    APMIS; 2007 Feb; 115(2):152-63. PubMed ID: 17295682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clear cell carcinoid tumor of stomach. A variant mimicking gastric xanthelasma.
    Luk IS; Bhuta S; Lewin KJ
    Arch Pathol Lab Med; 1997 Oct; 121(10):1100-3. PubMed ID: 9341592
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Production of basic fibroblast growth factor by gastric carcinoid tumors and their putative cells of origin.
    Bordi C; Falchetti A; Buffa R; Azzoni C; D'Adda T; Caruana P; Rindi G; Brandi ML
    Hum Pathol; 1994 Feb; 25(2):175-80. PubMed ID: 8119718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression and localization of chromogranin A gene and protein in human submandibular gland.
    Saruta J; Tsukinoki K; Sasaguri K; Ishii H; Yasuda M; Osamura YR; Watanabe Y; Sato S
    Cells Tissues Organs; 2005; 180(4):237-44. PubMed ID: 16330879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endocrine and tumor differentiation markers in poorly differentiated small-cell carcinoids of the cervix and vagina.
    Ulich TR; Liao SY; Layfield L; Romansky S; Cheng L; Lewin KJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1054-7. PubMed ID: 3022670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and histopathological tumour progression in ECL cell carcinoids ("ECLomas").
    Qvigstad G; Falkmer S; Westre B; Waldum HL
    APMIS; 1999 Dec; 107(12):1085-92. PubMed ID: 10660138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell and tumour biology of the gastric enterochromaffin-like cell.
    Modlin IM; Tang LH
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S117-30. PubMed ID: 10604115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromogranin A induces the biogenesis of granules with calcium- and actin-dependent dynamics and exocytosis in constitutively secreting cells.
    Elias S; Delestre C; Ory S; Marais S; Courel M; Vazquez-Martinez R; Bernard S; Coquet L; Malagon MM; Driouich A; Chan P; Gasman S; Anouar Y; Montero-Hadjadje M
    Endocrinology; 2012 Sep; 153(9):4444-56. PubMed ID: 22851679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chromogranin A as a determinant of midgut carcinoid tumour volume.
    Kölby L; Bernhardt P; Swärd C; Johanson V; Ahlman H; Forssell-Aronsson E; Stridsberg M; Wängberg B; Nilsson O
    Regul Pept; 2004 Aug; 120(1-3):269-73. PubMed ID: 15177946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine differentiation in gastric adenocarcinomas associated with severe hypergastrinemia and/or pernicious anemia.
    Qvigstad G; Qvigstad T; Westre B; Sandvik AK; Brenna E; Waldum HL
    APMIS; 2002 Feb; 110(2):132-9. PubMed ID: 12064868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Ovarian carcinoid tumors: immunohistochemical and ultrastructural study of 8 cases].
    Braunschweig R; Hurlimann J; Gloor E; Campiche M
    Ann Pathol; 1994; 14(3):155-62. PubMed ID: 8037803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of connective tissue growth factor and IGF1 in normal and neoplastic gastrointestinal neuroendocrine cells and their clinico-pathological significance.
    Kaltsas GA; Cunningham JL; Falkmer SE; Grimelius L; Tsolakis AV
    Endocr Relat Cancer; 2011 Feb; 18(1):61-71. PubMed ID: 20959439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electron-microscopic study of neuroendocrine tumors of the lung].
    Kats VA; Iagubov AS; Dumanian DG
    Arkh Patol; 1987; 49(3):12-20. PubMed ID: 3036047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chromogranin A: its clinical value as marker of neuroendocrine tumours.
    Nobels FR; Kwekkeboom DJ; Bouillon R; Lamberts SW
    Eur J Clin Invest; 1998 Jun; 28(6):431-40. PubMed ID: 9693933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chromogranin A in blood--a useful tumor marker].
    Syversen U; Heide LS; Waldum HL
    Tidsskr Nor Laegeforen; 1997 Oct; 117(26):3810-1. PubMed ID: 9417686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis.
    Kim T; Tao-Cheng JH; Eiden LE; Loh YP
    Cell; 2001 Aug; 106(4):499-509. PubMed ID: 11525735
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastric carcinoids.
    Bordi C
    Ital J Gastroenterol Hepatol; 1999 Oct; 31 Suppl 2():S94-7. PubMed ID: 10604110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular expression and specific intragranular localization of chromogranin A, chromogranin B, and synaptophysin during ontogeny of pancreatic islet cells: an ultrastructural study.
    Lukinius A; Stridsberg M; Wilander E
    Pancreas; 2003 Jul; 27(1):38-46. PubMed ID: 12826904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogold detection of chromogranin A in the neuroendocrine tumor.
    Silver MM; Lines LD; Hearn SS
    Ultrastruct Pathol; 1993; 17(1):83-92. PubMed ID: 8427030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.